A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) | MicrobiomeTrials← Back to trialsNCT07037771
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-06-17Est. Completion: 2027-08-20
Enrollment target: 60 participants Locations- Research Site 7, Park Ridge, Illinois, United States
- Research Site 2, New York, New York, United States
- Research Site 1, Cincinnati, Ohio, United States
- Research Site 14, Pittsburgh, Pennsylvania, United States
- Research Site 13, Camperdown, New South Wales, Australia
- Research Site 9, Saint Leonards, New South Wales, Australia
- Research Site 21, Heidelberg, Victoria, Australia
- Research Site 3, Nedlands, Western Australia, Australia
- Research Site 40, Innsbruck, Austria
- Research Site 39, Linz, Austria
- Research Site 42, Vienna, Austria
- Research Site 37, Vienna, Austria
- Research Site 33, La Louvière, Belgium
- Research Site 34, Leuven, Belgium
- Research Site 24, Cerqueira César, São Paulo, Brazil
- Research Site 5, Vancouver, British Columbia, Canada
- Research Site 6, Chicoutimi, Quebec, Canada
- Research Site 4, Québec, Canada
- Research Site 30, Hradec Králové, Czechia
Other microbiome trials you might be interested in
Homozygous Familial Hypercholesterolemic
Homozygous familial hypercholesterolemia is a rare inherited disease of metabolism. It occurs in less than 1 in 1 millio…
Bethesda, United States
Homozygous Familial Hypercholesterolemia
This study will evaluate the efficacy and safety of zodasiran subcutaneous (sc) injection in participants 12 to \<18 yea…
Multiple LocationsEst. completion Jul 2028
Research Site 23, Paris, FranceResearch Site 17, Tbilisi, GeorgiaResearch Site 18, Tbilisi, GeorgiaResearch Site 19, Tbilisi, GeorgiaResearch Site 35, Berlin, GermanyResearch Site 10, Jerusalem, IsraelResearch Site 15, Tel Litwinsky, IsraelResearch Site 26, Kanazawa, Ishikawa-ken, JapanResearch Site 27, Suita, Osaka, JapanResearch Site 20, Fukushima, JapanResearch Site 16, Okayama, JapanResearch Site 22, Saitama, JapanResearch Site 25, Tokyo, JapanResearch Site 12, Christchurch, New ZealandResearch Site 31, Riyadh, Saudi ArabiaResearch Site 11, Parktown, Johannesburg, South AfricaResearch Site 8, Cape Town, South AfricaResearch Site 43, Barcelona, SpainResearch Site 28, Córdoba, SpainResearch Site 29, Madrid, SpainResearch Site 32, Gothenburg, SwedenResearch Site 36, Afyonkarahisar, Turkey (Türkiye)Research Site 41, Bornova/Izmir, Turkey (Türkiye)Research Site 38, Melikgazi/Kayseri, Turkey (Türkiye)